Akèy › Kansè tete negatif triple › Georgia › Augusta
Etid klinik pou Kansè tete negatif triple nan Augusta, GA
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Augusta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
- Augusta University, Augusta
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- Augusta University Georgia Cancer Center, Augusta
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Ap rekriteFaz 1/2
- Georgia Cancer Center, Augusta
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Augusta
- Leksemi mieloïd egi10 etid
- Kansè ovè8 etid
- Kansè (tout kalite)7 etid
- Kansè Endomèt7 etid
- Maladi selil fòs5 etid
- Kansè nan tete5 etid
- Limfòm Non-Hodgkin4 etid
- Limfom Difize Gwo Selil B4 etid
- Lukemi miyoyid kwonik4 etid
- Kansè san4 etid
- Kansè kol4 etid
- Miasteni grav4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.